多功能DNA纳米材料:在类风湿性关节炎的诊断和治疗方面是一个新的前沿
Yiyi Zhang1,2, Yue Sun1,2, Hang Liao3
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China. sirongshi@scu.edu.cn.
Nanoscale
|January 2, 2025
概括
DNA纳米技术为风湿性关节炎 (RA) 治疗和诊断提供了新的希望. DNA纳米材料显示了针对药物输送和生物标志物检测的潜力,为个性化医疗铺平了道路.
科学领域:
- 生物技术和纳米医学
- 免疫学和风湿病学
背景情况:
- 类风湿性关节炎 (RA) 由于其异质性质,在治疗和诊断方面存在复杂的挑战.
- DNA纳米技术已经成为解决这些复杂性的强大工具.
研究的目的:
- 审查DNA纳米材料在类风湿性关节炎 (RA) 的应用.
- 探索DNA纳米结构,DNA吸收体和DNA修饰纳米粒子在RA治疗和诊断中的潜力.
主要方法:
- 关于DNA纳米技术在RA应用的当前文献的综述.
- 将DNA纳米材料分类为纳米结构,体和改性纳米粒子.
- 在RA的背景下分析它们的特性,优势和局限性.
主要成果:
- DNA纳米结构 (例如,tFNA,DNA原形) 具有抗炎作用,并可控制药物输送.
- 在生物标志物检测和治疗方面,DNA体具有高的特异性和稳定性,其性能优于传统抗体.
- 经过DNA修改的纳米粒子在生物成像和药物输送方面表现有前途,尽管RA应用需要进一步研究.
结论:
- DNA纳米材料具有显著的潜力,可以彻底改变RA治疗和诊断.
- 刺激反应系统可以提高药物释放效率和特异性.
- 解决稳定性,安全性和监管障碍等挑战对于临床翻译至关重要.
相关概念视频
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
T Cell Types and Functions
946
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
946
Connective Tissue Cell Types
3.1K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.1K


